Finasteride competitively and specifically inhibits 5-alpha-reductase that metabolizes testosterone to dihydrotestosterone (DHT) in the prostate gland, liver and skin. Development of prostate gland is dependent on DHT. Finasteride has no affinity for the androgen receptor and the hypothalamic pituitary-testicular axis does not appear to be affected.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
